The incidence of CCL2, CCL5, TNFα and IL-1β expression in the normal epithelium was not significantly different between DCIS and IDC-no-relapse, and also did not differ significantly between DCIS and IDC-with-relapse patients. This evidence concerns the gene IL1B and ductal breast carcinoma in situ.